Lipocine Stock Price on June 25, 2024
| LPCN Stock | USD 4.72 0.17 3.48% |
Below is the normalized historical share price chart for Lipocine extending back to June 15, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Lipocine stands at 4.72, as last reported on the 18th of November 2024, with the highest price reaching 4.97 and the lowest price hitting 4.63 during the day.
If you're considering investing in Lipocine Stock, it is important to understand the factors that can impact its price. Lipocine appears to be somewhat reliable, given 3 months investment horizon. Lipocine has Sharpe Ratio of 0.11, which conveys that the firm had a 0.11% return per unit of risk over the last 3 months. By analyzing Lipocine's technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please exercise Lipocine's Mean Deviation of 3.25, downside deviation of 4.31, and Risk Adjusted Performance of 0.0991 to check out if our risk estimates are consistent with your expectations.
At this time, Lipocine's Total Stockholder Equity is very stable compared to the past year. As of the 18th of November 2024, Common Stock Total Equity is likely to grow to about 10.7 K, while Other Stockholder Equity is likely to drop about 147.6 M. . At this time, Lipocine's Price Book Value Ratio is very stable compared to the past year. As of the 18th of November 2024, Price To Book Ratio is likely to grow to 0.76, though Price To Sales Ratio is likely to grow to (4.90). Lipocine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 22nd of October 2013 | 200 Day MA 5.2703 | 50 Day MA 5.0242 | Beta 1.188 |
Lipocine |
Sharpe Ratio = 0.1116
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | LPCN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.56 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.51 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Lipocine is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lipocine by adding it to a well-diversified portfolio.
Price Book 1.368 | Enterprise Value Ebitda 0.651 | Price Sales 5.4472 | Shares Float 5.2 M | Wall Street Target Price 21.5 |
Lipocine Main Headline on 25th of June 2024
Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Br... by finance.yahoo.com
Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced positive topline study results demonstrating bioequivalence of LPCN 1154 to IV brexanolone in an NDA enabling pivotal pharmacokinetic study. Lipocine is developing LPCN 1154, oral brexanolone, for the treatment of postpartum depression . The U.S. Food Drug Administration has agreed with Lipocines propo
Lipocine Valuation on June 25, 2024
It is possible to determine the worth of Lipocine on a given historical date. On June 25, 2024 Lipocine was worth 8.5 at the beginning of the trading date compared to the closed value of 8.15. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lipocine stock. Still, in general, we apply an absolute valuation method to find Lipocine's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lipocine where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lipocine's related companies.
| Open | High | Low | Close | Volume | |
| 8.94 | 9.89 | 8.75 | 9.30 | 95,654 | |
06/25/2024 | 8.50 | 8.68 | 7.72 | 8.15 | 104,730 |
| 8.08 | 8.18 | 7.39 | 7.85 | 60,699 |
| Backtest Lipocine | | | Lipocine History | | | Lipocine Valuation | Previous | Next |
Lipocine Trading Date Momentum on June 25, 2024
| On June 26 2024 Lipocine was traded for 7.85 at the closing time. The top price for the day was 8.18 and the lowest listed price was 7.39 . The trading volume for the day was 60.7 K. The trading history from June 26, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 3.68% . The trading delta at closing time against the current closing price is 3.44% . |
Lipocine Fundamentals Correlations and Trends
By evaluating Lipocine's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lipocine's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lipocine financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lipocine Stock history
Lipocine investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lipocine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lipocine will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lipocine stock prices may prove useful in developing a viable investing in Lipocine
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 5.3 M | 5.5 M | |
| Net Loss | -12.4 M | -13 M |
Lipocine Quarterly Net Working Capital |
|
Lipocine Stock Technical Analysis
Lipocine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Lipocine Period Price Range
Low | November 18, 2024
| High |
0.00 | 0.00 |
Lipocine cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Lipocine November 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Lipocine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lipocine shares will generate the highest return on investment. By undertsting and applying Lipocine stock market strength indicators, traders can identify Lipocine entry and exit signals to maximize returns
Lipocine Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lipocine's price direction in advance. Along with the technical and fundamental analysis of Lipocine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lipocine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0991 | |||
| Jensen Alpha | 0.5238 | |||
| Total Risk Alpha | (0.05) | |||
| Sortino Ratio | 0.1 | |||
| Treynor Ratio | 11.1 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.75) | Revenue Per Share 0.903 | Quarterly Revenue Growth 137.519 | Return On Assets (0.23) | Return On Equity (0.34) |
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.